Drug Topics

JUNE 25, 2025

1,2 “There is an extraordinary unmet need in obesity treatment, which is the ability for patients to stop GLP-1 drugs without regaining weight. 1 “These early Revita data are better than I expected and suggest the potential to prevent the weight regain we see in practice.

HIV Treatment and Prevention Agents 247

HIV Treatment and Prevention Agents Compounding Specialty Pharmacies Independent Pharmacies 247

Pharmaceutical Technology

JUNE 11, 2025

The US Food and Drug Administration (FDA) has placed a clinical hold on several of Gilead’s trials evaluating two HIV treatment candidates, though the rest of the drugmaker’s diverse pipeline remains unaffected. Gilead is considered the leading big pharma in HIV treatments. Shares in Nasdaq-listed Gilead opened 0.3%

HIV Treatment and Prevention Agents 52

HIV Treatment and Prevention Agents FDA Communication Hospitals 52

Pharmacy Times

JUNE 23, 2025

The presentation emphasized early intervention and personalized treatment plans in managing type 2 diabetes, shifting from "treating to failure" to "treating to target." It is not indicated for type 1 diabetes and carries a boxed warning for thyroid C-cell tumors, with unknown risk in humans.

HIV Treatment and Prevention Agents 73

HIV Treatment and Prevention Agents Compounding Pharmacies Immunization FDA 73

Pharmacy Times

JUNE 16, 2025

Although the use of colony-stimulating factors (CSFs) is well-established in mitigating severe FN, existing literature suggests there is only an approximate 3% difference in FN rates between various CSF agents.

HIV Treatment and Prevention Agents 73

HIV Treatment and Prevention Agents Chemotherapy Compounding Pharmacies Immunization 73

Pharmacy Times

JUNE 10, 2025

3 Although meloxicam injection delivers a non-opioid alternative for pain control, it is not recommended as a first-line agent when rapid onset of analgesia is needed due to its delayed onset. 2 REFERENCES 1.

FDA 73

FDA HIV Treatment and Prevention Agents Compounding Pharmacies Hospitals 73

The Checkup by Singlecare

SEPTEMBER 26, 2023

Examples of statins that can interact with Paxlovid include: Zocor ( simvastatin ) Lipitor ( atorvastatin ) Mevacor ( lovastatin ) Crestor ( rosuvastatin ) Simvastatin and lovastatin should not be taken at least 12 hours before the first Paxlovid dose, throughout treatment, and five days after completing Paxlovid.

HIV Treatment and Prevention Agents 52

HIV Treatment and Prevention Agents Dosage Adverse Reactions Immunization 52

Pharmacy Friday Pearls

MARCH 4, 2022

18 years Administration Oral Oral Oral PK/PD MOA: Nirmatrelvir – inhibitor of the SARS-CoV-2 main protease Prevents viral replicationRitonavir is a CYP3A inhibitor included to increase nirmatrelvir plasma levelsRitonavir alone has NO activity against SARS-CoV-2 Time to peak: Nirmatrelvir: 3 hrs & Ritonavir: 3.98 Introduction.

HIV Treatment and Prevention Agents 40

HIV Treatment and Prevention Agents Hospitals Packaging Immunization 40